| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.07 |